Evaluation of the Effect of Zinc Citrate Trihydrate Toothpaste on the Oral Plaque Microbiome
1 other identifier
interventional
142
0 countries
N/A
Brief Summary
This study is of a double-blind, randomised, parallel group study. Subjects will be enrolled onto the study according to the inclusion/exclusion criteria. After recruitment, subjects will be given a fluoride toothpaste without gum care agents to use for the 4-week run-in period prior to the commencement of the test phase of the study. Following the run-in period, baseline supragingival plaque samples will be collected 12 hours after last brushing, from the upper and lower jaws separately. Subjects will then then randomly allocated to one of two products (zinc citrate trihydrate \[ZCT\] toothpaste or control toothpaste) according to the randomization. Subjects will be instructed to use the toothpaste at home, brushing twice a day for 12-weeks. Supragingival plaque samples will be collected again from the upper and lower jaws after 2, 6 and 12 weeks. Plaque samples will then undergo metataxonomic and metatranscriptomic analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2017
CompletedFirst Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedApril 11, 2024
March 1, 2023
4 months
April 5, 2024
April 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plaque microbiome
Speciation of plaque bacteria
6 weeks
Study Arms (2)
ZCT toothpaste
EXPERIMENTALBrush with zinc citrate trihydrate toothpaste twice per day, morning and evening, for 12 weeks
Control toothpaste
PLACEBO COMPARATORBrush with control toothpaste twice per day, morning and evening, for 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy, adult, male/female volunteers
- Aged between 18 and 65 years old
- Willing to sign an informed consent and complete a medical history questionnaire
- Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant
- Must be available for the duration of the study
You may not qualify if:
- The subject is an employee of Unilever or the site conducting the study
- Subjects taking part in other oral care studies for the Sponsor or any other company
- Smokers (including eCigarettes) or those who have smoked in the preceding 12 months.
- Subjects showing unwillingness, inability or lack of motivation to carry out the study procedures
- Subjects who are pregnant or nursing
- Subjects who have used mouthwashes within the 4 weeks prior to the start of the study.
- Subjects with a Modified Gingival Index score of 3 at screening
- Diabetics
- Subjects showing signs of early or untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, would affect either the scientific validity of the study or, if the subject was to participate in the study, would affect their wellbeing.
- Subjects who have full or partial dentures or any oral piercings
- Subjects who have an active oral herpetic lesion or regularly suffer with oral herpetic lesions
- Subjects who regularly use medication or food supplements (including supplements which contain Zinc) in the 4 weeks prior to the start of the study, or during the study
- Known allergies to the toothpaste ingredients or to any dental materials
- Taking a course of antimicrobial medication within 4 weeks of screening or during the study
- Long term use of anti-inflammatory and/or antihistamine drugs. Intermittent use is permitted apart from 24 hours prior to the assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
- Intertekcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Maclure, BDS
Intertek CRS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Toothpaste packaged in white tubes with a study label which only differentiates products with a alphanumeric code.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 11, 2024
Study Start
January 10, 2017
Primary Completion
May 19, 2017
Study Completion
May 19, 2017
Last Updated
April 11, 2024
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share